(15053003), T. W. C., (11929719), C. H., (15053006), R. H., (14954275), J. L., (15053009), K. C., (15053012), C. Y., . . . (15053027), C. Y. (2025). Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma.
Čikaški stil citiranja (17. izdanje)(15053003), Tom Wei-Wu Chen, et al. Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. 2025.
MLA način citiranja (9. izdanje)(15053003), Tom Wei-Wu Chen, et al. Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. 2025.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.